Codexis (CDXS) Change in Receivables (2010 - 2019)
Codexis (CDXS) recorded quarterly Change in Receivables of -$3.3 million in Q4 2019, down 741.63% quarter-over-quarter from $514000.0 in Q3 2019, and down 227.04% on a YoY basis from $2.6 million in Q4 2018.
Codexis (CDXS) Change in Receivables (2010 - 2019) Analysis & Trends
Codexis' Change in Receivables history runs 10 years deep, the most recent figure standing at -$3.3 million for Q4 2019.
- In Q4 2019, Change in Receivables fell 227.04% year-over-year to -$3.3 million; the TTM figure through Dec 2019 stood at -$2.5 million (down 162.71% YoY), while the FY2019 annual figure was -$2.5 million, down 162.71% from the prior year.
- Change in Receivables was -$3.3 million for Q4 2019 at Codexis, down from $514000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $10.8 million in Q3 2015 to a low of -$6.3 million in Q4 2015.
- Historically, Change in Receivables has averaged $193500.0 across 5 years, with a median of -$460000.0 in 2015.
- Biggest YoY gain for Change in Receivables was 5389.34% in 2015; the steepest drop was 961.32% in 2015.
- A 5-year view of Change in Receivables shows it stood at -$6.3 million in 2015, then advanced by 3.79% to -$6.0 million in 2016, then soared by 158.62% to $3.5 million in 2017, then slipped by 26.69% to $2.6 million in 2018, then tumbled by 227.04% to -$3.3 million in 2019.
- The last three Change in Receivables figures came in at -$3.3 million (Q4 2019), $514000.0 (Q3 2019), and -$791000.0 (Q2 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -4.08 Mn |
| 10 | Codexis | 226.01 Mn | 160.87 Mn | 13.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -3.30 Mn |
| Dec 31, 2019 | -3.30 Mn |
| Sep 30, 2019 | 514,000.00 |
| Sep 30, 2019 | 514,000.00 |
| Jun 30, 2019 | -791,000.00 |
| Jun 30, 2019 | -791,000.00 |
| Mar 31, 2019 | 1.05 Mn |
| Mar 31, 2019 | 1.05 Mn |
| Dec 31, 2018 | 2.60 Mn |
| Dec 31, 2018 | 2.60 Mn |
| Sep 30, 2018 | -499,000.00 |
| Sep 30, 2018 | -499,000.00 |
| Jun 30, 2018 | 546,000.00 |
| Jun 30, 2018 | 546,000.00 |
| Mar 31, 2018 | -3.60 Mn |
| Mar 31, 2018 | -3.60 Mn |
| Dec 31, 2017 | 3.54 Mn |
| Dec 31, 2017 | 3.54 Mn |
| Sep 30, 2017 | -122,000.00 |
| Sep 30, 2017 | -122,000.00 |